Please complete the CAPTCHA to continue
@grunenthal.com
✓
LinkedIn matched
A concise factual answer block for searchers comparing this professional profile.
Shlomo Meislin Harnas is listed as Life Sciences Commercial Strategy | BD Evaluation & Diligence | BioPharma | MedTech | Rare Disease at Akrolyth Advisory, based in Denver Metropolitan Area, United States, United States. AeroLeads shows a work email signal at grunenthal.com and a matched LinkedIn profile for Shlomo Meislin Harnas.
Shlomo Meislin Harnas previously worked as Managing Director at Akrolyth Advisory and Member/Investor at Mid Atlantic Bio Angels. Shlomo Meislin Harnas holds S.M., Biology from Massachusetts Institute Of Technology.
This section adds company-level context without repeating Shlomo Meislin Harnas's masked contact details.
AeroLeads found 1 current-domain work email signal for Shlomo Meislin Harnas. Compare company email patterns before reaching out.
An experienced healthcare and Life Science commercial strategy professional, Shlomo has worked extensively across consulting and industry – with biopharma and medtech companies, startups, and investors on evaluating, developing, and commercializing new therapies and products.Particular focus on commercial strategy and business planning, evaluation/diligence, and acquisition/licensing support, new product and portfolio development, forecasting and analytics, and market entry strategy in the US, EU, and emerging markets (LatAm, BRIC). Experience covers a broad range of therapeutic areas, particularly orphan/rare disease and specialty therapeutics. Especially valued throughout his career for depth of insight, versatility and speed in gaining subject expertise, and ability to readily navigate complexity and provide structure and clarity to challenging questions.
Listed skills include Management Consulting, Lifesciences, Biochemistry, Microsoft Office, and 8 others.
Company context helps verify the profile and gives searchers a useful next step.
A career timeline built from the work history available for this profile.
Support pharma, biotech, medtech, and investors on projects that require non-standard, customized approaches combining extensive analytical acumen with in-depth commercial and market knowledge.- Fractional/contract VP, directly supporting CEOs and CCOs with commercial strategy, operational planning, scenario development and modeling/forecasting.
New York, NY, US
Mid Atlantic Bio Angels group (MABA) is an angel investor group focused on new and emerging life science companies.
Greenwich, CT, US
Strategy, development, and BD/diligence advisor for various medical device and health technology startups and development-stage companies, as well as angel investor.
Dallas, Texas, US
Advise MedTech company on commercial/growth strategy and due diligence prep.
Aachen, DE
North America Commercial voice within global organization, reporting directly to the U.S. CEO. Responsible for business planning, acquisition/licensing evaluations, U.S. market entry strategy, and forecasting/analytics on licensed portfolio. Commercial lead for mid-late stage rare/orphan portfolio (Interim).
Chicago, IL, US
Go-to engagement leader for due diligence and licensing/acquisition support - involved in >70% of the Life Science global practice's due diligence & forecasting projects across pharma, biotech, and medtech, leading teams across 3 continents.Further work on numerous commercial strategy, market entry, and launch planning projects for pharmaceuticals.
Led and executed projects focusing on rare disease, developing markets, and commercial due diligence.Moved to Navigant upon their acquisition of Leerink's consulting group.
Particular focus on new product/portfolio strategy, due diligence and LM&A support, and rare disease. Led teams of 2-5, with consistently high praise for project quality and mentoring. Teamwork award winner.
Cambridge, MA, US
Advisors: Dr. Phillip A. Sharp and Dr. Laurie A. Boyer, MIT Department of Biology
Chevy Chase, Maryland, US
Advisor: Dr. Melissa J. Moore., Howard Hughes Medical Institute and Brandeis University Department of Biochemistry
Quick answers generated from the profile data available on this page.
Shlomo Meislin Harnas works for Akrolyth Advisory.
Shlomo Meislin Harnas is listed as Life Sciences Commercial Strategy | BD Evaluation & Diligence | BioPharma | MedTech | Rare Disease at Akrolyth Advisory.
AeroLeads has found 1 work email signal at @grunenthal.com for Shlomo Meislin Harnas at Akrolyth Advisory.
Shlomo Meislin Harnas is based in Denver Metropolitan Area, United States, United States while working with Akrolyth Advisory.
Shlomo Meislin Harnas has worked for Akrolyth Advisory, Mid Atlantic Bio Angels, Various Companies, Articulate Labs, and Grünenthal Group.
You can use AeroLeads to view verified contact signals for Shlomo Meislin Harnas at Akrolyth Advisory, including work email, phone, and LinkedIn data when available.
Shlomo Meislin Harnas holds S.M., Biology from Massachusetts Institute Of Technology.
Shlomo Meislin Harnas is listed with skills including Management Consulting, Lifesciences, Biochemistry, Microsoft Office, Biopharmaceuticals, Consulting, Healthcare, and Pharmaceutical Industry.
Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.
Start free trial Search contacts